Anika Therapeutics, Inc. (ANIK) Reports Q2 Earnings of $0.17, Revenues Increase Y/Y
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $14.42 +1.34%
EPS Growth %: +115.4%
Financial Fact:
Net income: 0.59
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +115.4%
Financial Fact:
Net income: 0.59
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q2 EPS of $0.17, versus $0.08 reported last year. Revenue for the quarter came in at $16.1 million, versus $13.7 million reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Rochon family buys $100M in AIAI Holdings shares at $20 each
- HCB shareholders approve Independent Bank's acquisition deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
